Who owns INVO BIOSCIENCE INCORPORATED COM NEW?
- Ticker: INVO
- CUSIP Number: 44984f401
Tip: Access positions for across all investors
Analyze quarterly positions in Invo Bioscience Incorporated with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Invo Bioscience Incorporated stock
Who bought or sold INVO BIOSCIENCE INCORPORATED COM NEW this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
CWC Advisors | 101k | $71k | 100% | Sep 2024 |
|
Vanguard Group | 54k | $45k | 0% | Jun 2024 |
|
Citadel Advisors | 53k | $37k | 100% | Sep 2024 |
|
Geode Capital Management | 35k | $25k | 8% | Sep 2024 |
|
Two Sigma Securities | 16k | $13k | 100% | Jun 2024 |
|
Tower Research Capital | 5.1k | $4.3k | -26% | Jun 2024 |
|
Wells Fargo & Company | 250.00 | $178.000000 | 100% | Sep 2024 |
|
Advisor Group Holdings | 250.00 | $177.000000 | -55% | Sep 2024 |
|
Qube Research & Technologies | 100.00 | $86.000000 | 100% | Jun 2024 |
|
Morgan Stanley | 37.00 | $30.998600 | 0% | Jun 2024 |
|
Bank of America Corporation | 31.00 | $22.000700 | 11% | Sep 2024 |
|
Gleason Group | 3.00 | $2.000100 | 0% | Sep 2024 |
|
Who sold out of Invo Bioscience Incorporated?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Jun 2024 | 12k | $11k |
Royal Bank of Canada | Jun 2024 | 438.00 | $0 |